Molecular Data Inc. Announces Change of Independent Registered Public Accounting Firm
October 23 2020 - 7:50AM
Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq:
MKD), a leading technology-driven platform in China’s chemical
industry, today announced that, effective October 23, 2020, the
Company has appointed Marcum Bernstein & Pinchuk LLP
(“MarcumBP”) as the Company’s independent registered public
accounting firm. Ernst & Young Hua Ming LLP (“E&Y”) didn’t
stand for re-election as the Company’s independent registered
public accounting firm. The change of the Company’s independent
registered public accounting firm has been approved by both the
audit committee and the board of directors of Molecular Data, and
was not the result of any disagreement between the Company and
E&Y on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure.
The reports of E&Y on the Company’s consolidated financial
statements for the fiscal years ended December 31 between 2016 and
2019 have contained no adverse opinion or disclaimer of opinion and
were not qualified or modified as to uncertainty, audit scope or
accounting principles.
During the Company's fiscal years ended December 31, 2017, 2018
and 2019 and through the subsequent interim period on or prior to
October 23, 2020, neither the Company nor anyone on its behalf has
consulted with MarcumBP on either (a) the application of accounting
principles to a specified transaction, either completed or
proposed, or the type of audit opinion that might be rendered on
the Company’s financial statements, and neither a written report
nor oral advice was provided to the Company by MarcumBP which
MarcumBP concluded as an important factor considered by the Company
in reaching a decision as to any accounting, auditing or financial
reporting issue, or (b) any matter that was the subject of a
disagreement, as that term is defined in Item 16F(a)(1)(iv) of Form
20-F (and the related instructions thereto) or a reportable event
as set forth in Item 16F(a)(1)(v)(A) through (D) of Form 20-F.
About Molecular Data Inc.
Molecular Data Inc. is a leading technology-driven platform in
China’s chemical industry, connecting participants along the
chemical value chain through integrated solutions. The Company
delivers e-commerce solutions, financial solutions, warehousing and
logistics solutions, and SaaS suite that are intended to solve pain
points for participants in the traditional chemical industry. Built
upon a comprehensive knowledge engine and artificial intelligence
(AI) capabilities, the Company’s e-commerce solutions are mainly
offered through its online platform, consisting of molbase.com,
molbase.cn, Moku Data WeChat account, Chemical Community APP and
other ancillary platforms.
For investor and media inquiries, please
contact:
In China:
Molecular Data Inc.Eva MaTel: +86-21-5419-9057E-mail:
investor@molbase.com
The Piacente Group, Inc.Emilie WuTel:
+86-21-6039-8363E-mail: molbase@tpg-ir.com
In the United States:
The Piacente Group, Inc.Brandi PiacenteTel:
+1-212-481-2050E-mail: molbase@tpg-ir.com
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Apr 2024 to May 2024
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From May 2023 to May 2024